Exposure to fruit-flavoring during adolescence increases nicotine consumption and promotes dose escalation.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Patten (2021)
The interactive effects of JUUL flavor and nicotine concentration on addiction potential.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Peasley-Miklus (2023)
Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Phillips-Waller (2021)
Use of E-cigarettes and Other Tobacco Products and Progression to Daily Cigarette Smoking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Pierce (2021)
Body esteem, weight-control outcome expectancies, and e-cigarette use among young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Pokhrel (2021)
Nicotine delivery and cigarette equivalents from vaping a JUULpod.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Prochaska (2022)
Effect of Puffing Behavior on Particle Size Distributions and Respiratory Depositions From Pod-Style Electronic Cigarette, or Vaping, Products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ranpara (2021)
Free Radical, Carbonyl, and Nicotine Levels Produced by Juul Electronic Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Reilly (2019)
Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on! nicotine pouches compared to combustible cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Rensch (2021)
Investigating the DNa methylation profile of e-cigarette use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Richmond (2021)